Malate dehydrogenase from Escherichia coli (eMDH) 1 catalyzes the interconversion of mala te and oxaloacetate, a critical step in carbohydrate metabolism. In eukaryotes the production of oxaloacetate in the mitochondria is required to accept the acetyl-coenzyme A that is generated from the catabolism of carbohydrates, lipids, and certain amino acids. The cytosolic form of this enzyme is involved in the malate/aspartate shuttle that exchanges reducing equivalents across the mitochondrial membrane. As expected for the catalysis of this important metabolic reaction, malate dehydrogenase in both prokaryotes and eukaryotes is highly selective for malate and oxaloacetate, with strong discrimination against other 2 -keto mono-and dicarboxylic acids (1). Examination of the crystal structure of malate dehydrogenase from E.
to obtain the kinetic parameters. Inhibition constants were determined by a Dixon analysis (6) and are corrected for the higher levels of substrates relative to their K m values. Protein concentration was determined by the Bradford method (7) using BSA as a standard.
Mutagenic Method -Site-directed mutagenesis was carried out by using recombinant circle PCR. The RC-PCR method (8, 9) utilizes four primers (two mutagenic and two nonmutagenic) that are designed to generate double stranded, linear DNA molecules with blunt ends.
Once combined, denatured and reannealed, this linear DNA produces double-stranded DNA with discrete cohesive single-stranded ends, in addition to the previously made blunt end molecules.
However, only the former PCR product will anneal to form recombinant circles of DNA that can effectively mimic the circular DNA that is necessary to be transformed into TG-1 cells. This method was successfully utilized for the production of the linear DNA that then allowed the creation of a mutagenic site within the malate dehydrogenase gene. The specific cha nges introduced were to alter the DNA sequence in the region of interest that codes for the amino acid at position 153 to ACa tAT GAT, where the mismatched bases to create the mutagenic arginine to cysteine replacement and the newly introduced Nde I restriction endonuclease site are shown in lower case, with the restriction site underlined. For the R153E mutant the sequence A TAT gga TTC was used to substitute a glutamate at this position and destroy the introduced Nde I restriction site. Initial screening for the presence of mutagenic colonies was accomplished by restriction enzyme mapping. 7 cysteine that was introduced is also modified under these conditions. However, when the titration with DTNB is conducted under non-denaturing conditions a slow modification (>30 min) is observed of a single cysteine per subunit in the native enzyme. The introduction of a cysteine at position 153 places a reactive nucleophile within the active site of eMDH. Incubation of the R153C mutant with DTNB under non-denaturing conditions leads to the rapid (<5 min) modification of a single cysteine. If the reaction is allowed to proceed fo r an extended period the slow modification of a second cysteine is observed. From the high reactivity of this first cysteine the site of modification in the mutant eMDH appears to be at the introduced cysteine-153. To support this assignment the rate of reaction of the slowly modified cysteine in the eMDH mutant was examined, and was found to be indistinguishable from that of the single accessible cysteine that is modified in the native enzyme.
Treatment of the R153C mutant with moderate levels of most of the amino acid analog reagents results in the selective modification of only the most reactive cysteine (1.0 ± 0.2 cysteines modified per subunit) that has been assigned to the cysteine introduced at position 153.
For the more reactive reagents, particularly those with bromide as the leaving group, both the introduced cysteine and the non-essential exposed cysteine can be modified (2.0 ± 0.2 cysteines modified per subunit) under these conditions at extended reaction times. However, even in these cases, the introduced cysteine shows significantly higher reactivity with these reagents than does the native cysteine. Modification of the native cysteine with DTNB, or with some of the more reactive amino acid analog reagents, has a negligible effect on the kinetics of native eMDH, with both k cat and k cat /K m for the modified enzyme remaining at 80 to 90% of the values for the unmodified enzyme.
Site Specific Modulation -Based on these results the R153C mutant can now be specifically chemically modulated by using various amino acid analog reagents to introduce a range of functional groups into the active site of eMDH. Modification of this introduced cysteine with 2-chloroacetamidine results in the incorporation of an acetamidine (AAn) group and thus the ge neration of a homoarginine analog. This new active site functional group does not lead to significant recovery of activity, however there is a 5-fold decrease in the K m for oxaloacetate to a value that is nearly 3-fold lower than that of the native enzyme (Table I ).
Modifications at this position to incorporate either amine (lysine analogs) or amide (glutamine analogs) functional groups at this position lead to modest changes in the kinetic parameters. In each case the longer homolog results in the greater improvement, with the propylamide (PAd)-modified enzyme having a k cat that is about 25% of the native enzyme and the propylamine (PAm)-modified enzyme at about 30% of the native k cat value (Table I) .
These modifications that have been introduced were aimed at generating reasonable structural analogs of the active site arginine that was removed. It is also possible to use this approach to characterize the role of an active site group by disrupting the enzyme-substrate interactions. Mutation of arginine-153 to glutamate places a negative charge in the vicinity of the substrate α-carboxyl binding site, and should result in decreased affinity for the physiological substrates. As expected, the K m for OAA increases but only by a factor of three. The position of this carboxyl group can be extended by the modulation of cysteine-153 with a halocarboxylic acid. Introduction of an acetate group leads to a further decrease in k cat and in k cat /K m to less than 10% of the values observed for the native enzyme (Table I) .
Inhibition Studies -The changes that have been introduced into the active site as a result of these chemical modulations were next investigated through a series of inhibition studies aimed at focusing exclusively on alterations in binding affinity. Generation of the R153C mutation results in an increase in the inhibition constant for pyruvate (a 3-carbon substrate analog) and α-ketoglutarate (a 5-carbon substrate analog) of 2-to 3-fold compared to that with the native enzyme (Table II) . Specific modifications of this introduced cysteine with a variety of amino acid analog reagents leads to further alterations in binding specificity. Modification of R153C through the introduction of an acetamidine (AAn) group at this position leads to enhanced bind ing for each inhibitor that was examined when compared to the unmodified mutant enzyme.
β-Ketoglutarate interacts with the AAn-modified enzyme 4-fold tighter than with the native enzyme, and the interaction with mercaptosuccinate is 6-fold tighter (both shown in bold in Table II ). The ethylamine-modified enzyme shows a similar increase in affinity for mercaptosuccinate.
Introduction of a carboxyl group at this position, by mutation of arginine-153 to glutamate, does not affect the binding of either pyruvate or β-ketoglutarate, but does cause a 3-fold decrease in the affinity of the enzyme for α-ketoglutarate. Extending the carboxylate further into the binding pocket by modification of R153C with an acetate group leads to a 4-fold decrease in the affinity for both α-and β-ketoglutarate, but has no effect on the binding of pyruvate when compared to the native enzyme.
For the hydroxyacid substrates the affinity of R153C for L-lactate, the 3-carbon analog of malate, decreases by over 20-fold when compared t o the native enzyme (Table II) . Native eMDH shows a 3-fold stereochemical discrimination for the binding of L-lactate as an inhibitor over the D-isomer, however this selectivity is reversed when arginine-153 is substituted by cysteine. There is a return to the stereochemical preference for binding the L-isomer of lactate over the D-isomer when this position is modified by the introduction of an acetamidine, an acetamide, or an ethylamine functional group (Table II) . In the case of the propylamine- Alternative Substrates -eMDH is highly selective for malate and oxaloacetate as substrates. However, when examined at sufficiently high concentrations several alternative substrates have been reported (1) . The reduction of α-ketoglutarate, the 5-carbon analog of OAA, is catalyzed at a rate that is only 2% that of the physiological substrate, and has a k cat /K m that is decreased by about 10 4 (Table III) Modification of R153C by the introduction of an acetamidine functional group does not result in recovery of the capability of the enzyme to reduce either α-ketoglutarate or hydroxypyruvate. In addition, the catalysis of pyruvate that was obtained upon replacement of arginine-153 with cysteine is lost when this introduced cysteine is modified (Table III) . Similar losses of activity are observed upon modification of cysteine-153 with either ethylamine or propylamine. However, the acetamidine-modified enzyme does retain the capability to reduce phenylpyruvate, with enhanced kinetic parameters to values that approach those observed with the native enzyme.
DISCUSSION

Specificity of Modification -Cysteines contain an inherently reactive sulfhydryl group
that is the most potent nucleophile among the naturally occurring amino acids. However, in proteins, these functio nal groups are frequently found either in disulfide linkages or in the solvent inaccessible interior (12). In most cases, treatment of proteins with thiol reagents under non-denaturing conditions will result in the modification of only the accessible surface cysteines.
Only one of the three cysteines per subunit that are found in native eMDH reacts with the amino acid analog reagents that have been examined, and this modification reaction is very slow despite a wide range in the inherent reactivity of the se reagents with sulfhydryl groups (13). An examination of the structure of eMDH shows that two of the cysteines in the native enzyme are buried in the protein interior and only one, the presumed site of reaction, is partially solvent by guest on October 1, 2017
exposed. Furthermore, the modification of this single cysteine has been shown to have a negligible effect on the kinetics of the reaction catalyzed by eMDH. The R153C mutant contains an additional cysteine that is modified by these reagents, and this introduced cysteine is significantly more reactive than the partially exposed native cysteine. Incubation of R153C eMDH with any of the amino acid analog reagents for short periods of time under nondenaturing conditions results in the modification of only the introduced cysteine. From these observations it appears that the modification of the introduced cysteine at position 153 is responsible for the kinetic changes that are observed.
Alterations in Substrate Specificity -Lactate and malate dehydrogenases are structurally and mechanistically related keto acid dehydrogenases (2, 15). The sequence identity between these related enzyme families is quite limited despite the overall structural similarities, however many of the functional active site amino acids are conserved between these enzyme families (16) . To demonstrate that these enzymes are functionally related several of the active site amino acids in the lactate dehydrogenase framework have been altered to the corresponding malate dehydrogenase residues by site-directed mutagenesis. Replacement of the glutamine-102 of lactate dehydrogenase (LDH) with an arginine resulted in the reversal of specificity, with the conversion of LDH to an eMDH with high specificity for oxaloacetate (17) . The corresponding replacement in eMDH resulted in an enzyme with broader specificity, but does not lead to a reversal of specificity (1) . Mutagenic replacements at several additional active site functional groups have confirmed the more stringent substrate specificity of eMDH over LDH (3).
Malate dehydrogenase is quite specific for the oxidation of L-malate and the reduction of OAA. No activity is observed with the 3-carbon keto acid analog pyruvate, and the activity with the 5-carbon analog α-ketoglutarate is diminished by nearly 10,000-fold when compared to the physiological substrate. The introduction of a hydroxyl or a phenyl group in place of the β-the substrate carboxyl group and the carboxyl group introduced at position 153 could be avoided by a rotation of the side chain into an alternative conformation (18) .
Modulation of Catalytic Activity -The introduction of a variety of arginine analogs has
led to an enhancement of the R153C mutant enzyme's capability to bind its substrates and competitive inhibitors. In a number of cases (shown in bold in Table II ) these introduced functional groups have resulted in improved affinity when compared to the native enzyme.
While similar variations are observed in catalytic activity among the modified enzymes, in no case does the activity exceed or even approach that of the native enzyme. The best recovery of activity was observed with the propylamine-modified enzyme, and even here k cat for malate is less than 20% and for OAA is about 30% of the native enzyme. These results clearly show that more stringent requirements must be met beyond the recovery of reasonable binding affinity in order to achieve enhanced catalysis.
For almost all of these modified enzymes there is little difference between the decreases in the catalytic efficiency of the enzyme that are observed under saturating substrate conditions (k cat ) and under limiting substrate conditions (k cat /K m ). Binding of the substrate at the enzyme active site is a necessary requirement for catalysis. However, efficient catalysis also requires precise positioning of the substrate in close proximity to the enzyme catalytic group and to the coenzyme for effective hydride transfer. These studies suggest that the primary role of the individual arginines at the active site of eMDH is not in substrate binding, but in substrate orientation. 
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